Pangea Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 28-12-2024
- Paid Up Capital ₹ 0.30 M
as on 28-12-2024
- Company Age 27 Year, 11 Months
- Last Filing with ROC 31 Mar 2007
- Open Charges ₹ 1.20 Cr
as on 28-12-2024
About Pangea Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2007. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹1.20 Cr.
Pathapati Raju, Pathapati Raju, and Pathapati Lakshmi serve as directors at the Company.
- CIN/LLPIN
U24230TG1997PLC026448
- Company No.
026448
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Feb 1997
- Date of AGM
27 Sep 2007
- Date of Balance Sheet
31 Mar 2007
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pangea Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pathapati Raju  | Managing Director | 18-Feb-1997 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pathapati Raju | Director | 30-Aug-1997 | Current |
| Pathapati Lakshmi | Director | 30-Aug-1997 | Current |
Financial Performance of Pangea Pharma.
Enhance accessibility to Pangea Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Pangea Pharma?
Unlock access to Pangea Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹11.96 M
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.63 Cr
- A.P. State Finance Corporation : 0.29 Cr
- Andhra Pradesh State Financial C0Rporation : 0.28 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jul 2006 | Andhra Pradesh State Financial C0rporation | ₹2.79 M | Open |
| 01 Dec 2001 | Punjab National Bank | ₹2.50 M | Open |
| 04 Sep 1999 | Punjab National Bank | ₹1.90 M | Open |
| 04 Sep 1999 | Punjab National Bank | ₹1.90 M | Open |
| 20 Jul 1998 | A.P. State Finance Corporation | ₹2.88 M | Open |
How Many Employees Work at Pangea Pharma?
Unlock and access historical data on people associated with Pangea Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pangea Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pangea Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
